Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon
→ Eli Lilly has appointed Procter & Gamble CEO Jon Moeller to the board of directors, while Goldman Sachs operating partner …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
